{
  "pmcid": "5430295",
  "sha256": "8cd91f5f55c78947c8b4b884500a0a1b5036a37dfb2a82fb3b91b93535dd9b44",
  "timestamp_utc": "2025-11-09T22:46:14.737782+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.023471760797342,
    "reading_ease": 36.21308139534884,
    "word_count": 215
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "The REDWASH Trial: A Randomised Controlled Trial of Red Blood Cell Washing in Cardiac Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "60 adult patients were randomised 1:1"
      },
      "Participants": {
        "score": 2,
        "evidence": "cardiac surgery patients at high risk of large-volume transfusion. Conducted at three UK cardiac centres"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 1:1 to receive either washed RBCs or standard care RBCs"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial evaluated the effects of washing allogeneic red blood cells (RBCs) on inflammation and organ injury"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was serum interleukin-8 (IL-8) measured at baseline and four postsurgery time points"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was stratified by study site and procedure type, with allocation concealed via an Internet-based system"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between May 2013 and March 2015, 29 patients were allocated to standard care and 27 to the washing group"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was intention-to-treat"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "no significant difference in IL-8 levels between groups [adjusted mean difference 0.239 (95% CI -0.231, 0.709), P=0.318]"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were not significantly different between groups"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial was registered under ISRCTN 27076315"
      },
      "Funding": {
        "score": 0,
        "evidence": "funded by [source not specified]"
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}